Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Davide Bedognetti, Ena Wang, Francesco M. Marincola

Research output: Contribution to journalEditorial

8 Citations (Scopus)
Original languageEnglish
Article numbere28727
JournalOncoImmunology
Volume3
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Immunotherapy
Meta-Analysis
Melanoma
Biomarkers
Breast Neoplasms
Gene Expression

Keywords

  • Biomarkers
  • Breast cancer
  • CXCL-13
  • gene signature
  • Gene-expression
  • Immunotherapy
  • Melanoma
  • Neoadjuvant chemotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this

@article{888c821085424310ae5500fa0a16aafc,
title = "Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome",
keywords = "Biomarkers, Breast cancer, CXCL-13, gene signature, Gene-expression, Immunotherapy, Melanoma, Neoadjuvant chemotherapy",
author = "Davide Bedognetti and Ena Wang and Marincola, {Francesco M.}",
year = "2014",
doi = "10.4161/onci.28727",
language = "English",
volume = "3",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Meta-analysis and metagenes

T2 - CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

AU - Bedognetti, Davide

AU - Wang, Ena

AU - Marincola, Francesco M.

PY - 2014

Y1 - 2014

KW - Biomarkers

KW - Breast cancer

KW - CXCL-13

KW - gene signature

KW - Gene-expression

KW - Immunotherapy

KW - Melanoma

KW - Neoadjuvant chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84902579138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902579138&partnerID=8YFLogxK

U2 - 10.4161/onci.28727

DO - 10.4161/onci.28727

M3 - Editorial

AN - SCOPUS:84902579138

VL - 3

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 4

M1 - e28727

ER -